Testing a new drug for hidradenitis suppurativa in people with excess weight
Part of Hormones & metabolism, Infections, Skin clinical trials.
This study tests an investigational medication (olatorepatide) given as a shot (under the skin) to see if it can reduce the number of painful bumps in people with moderate-to-severe hidradenitis suppurativa who also have overweight or obesity. Participants will receive either the active drug or a placebo, and all will use standard antiseptic washes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have had hidradenitis suppurativa (HS) for at least 6 months.
- You have HS bumps or abscesses in at least 2 different areas of your body.
- You have at least 5 active inflammatory bumps or abscesses at screening.
- You have a body mass index (BMI) of 27 or higher.
- You are willing to use daily over-the-counter antiseptic washes (like chlorhexidine or benzoyl peroxide) on your HS areas.
- You have not had recent heart problems, pancreatitis, or certain other serious medical conditions.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new medicine called HB0043 for people with moderate to severe hidradenitis suppurativa (a skin condition causing painful lumps). It aims to see if the drug is safe and helps reduce symptoms.
This trial tests a new medication, SAR445399, for people with moderate to severe hidradenitis suppurativa (HS) who haven't improved with oral antibiotics. It aims to see if the drug safely reduces skin bumps and abscesses.
This study tests a new drug called LAD328 for hidradenitis suppurativa (HS), a chronic skin condition with painful lumps and abscesses. The trial is looking for adults with moderate-to-severe HS who haven't responded well to antibiotics to see if this new treatment can help reduce symptoms.
This trial tests a new drug called Brivekimig for people with moderate to severe hidradenitis suppurativa (HS) who have not gotten enough relief from oral antibiotics. The goal is to see if it can reduce abscesses and inflamed bumps.
This study tests a new medicine called LAD191 for people with moderate to severe hidradenitis suppurativa (HS) who haven't been helped enough by antibiotics. Researchers want to see if LAD191 safely reduces painful bumps and tunnels.
This trial tests whether taking capsules containing healthy gut bacteria (fecal microbiota transplant) can help treat hidradenitis suppurativa. You may qualify if you have HS and haven't taken antibiotics in the last 30 days.
Hear when a new Hidradenitis Suppurativa trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.